Literature DB >> 3293493

A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome.

B Freundlich1, D Makover, G G Maul.   

Abstract

The association of malignancy with lupus-like syndromes is rare, and the relation between these two processes is uncertain. A 71-year-old woman who presented with serositis, Raynaud phenomenon, and positive results on an antinuclear antibody test was initially thought to have systemic lupus erythematosus but was found to have ovarian adenocarcinoma. A unique sparsely speckled antinuclear antibody pattern was seen. The patient's sera reacted to novel antigens with six bands of 100, 80-78, 48, and 17 kD on Western blots not typical of reactivity for sera from patients with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293493     DOI: 10.7326/0003-4819-109-4-295

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Positive antinuclear antibodies in malignancies.

Authors:  M Zuber
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 2.  Paraneoplastic rheumatic syndromes.

Authors:  Csilla András; Zoltán Csiki; Andrea Ponyi; Arpád Illés; Katalin Dankó
Journal:  Rheumatol Int       Date:  2005-08-10       Impact factor: 2.631

3.  A patient with a high titer of antinuclear antibody and a functioning adrenal tumour.

Authors:  M Zuber; R Miesel; B Brandl
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

4.  Antinuclear antibodies as potential markers of lung cancer.

Authors:  F Fernández-Madrid; P J VandeVord; X Yang; R L Karvonen; P M Simpson; M J Kraut; J L Granda; J E Tomkiel
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

5.  Chronic monoarthritis and foot-drop as a paraneoplastic syndrome in prostate cancer.

Authors:  Senol Kobak
Journal:  Rheumatol Int       Date:  2010-07-22       Impact factor: 2.631

6.  Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

Authors:  C Tolosa-Vilella; J Ordi-Ros; M Vilardell-Tarres; A Selva-O'Callaghan; R Jordana-Comajuncosa
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

7.  Identification of a novel nuclear domain.

Authors:  C A Ascoli; G G Maul
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

8.  Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin.

Authors:  L E Andrade; E K Chan; I Raska; C L Peebles; G Roos; E M Tan
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.